Investor Day & Networking Cocktail
Dr. Stephan Sigrist, founder of W.I.R.E, Think Tank for Business, Science & Society, a leading future-researcher, presenting a refreshing and eye-opening keynote focusing on the future of investing and finance in Switzerland.
We have selected a cohort of interesting Series A, B, C, and Pre-IPO opportunities in various industries. Most of the firms are former spin-offs from leading Swiss Universities, with high growth and value creation potential. Their CEO will present the business, the challenges, as well as the chances:
Embion Technologies Ltd. (
www.embiontech.com), industrial biotechnology and green chemistry company enabling new solutions to retrieve ingredients from industrial biomass. #Nutrition #Circulareconomy
KetoSwiss Ltd. (
www.keto.swiss), developing food supplements and therapeutic products targeting the root cause of metabolic migraines. Exit planned in 2025. #Brainfuels
Testmate Health Ltd. (
www.testmatehealth.com), their rapid-at-home urine-self-test provides results in minutes for sexually transmitted diseases (first application) and other diseases (upcoming). #Selftesting
Topadur Pharma Ltd. (www.topadur.com), clinical stage, developing drugs for the treatment of aging-related diseases, wound healing, eye diseases, colon cancer and medical cosmetics. Exit (IPO) planned in 2023
There is limited space available.
More about the Scaleups
